Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00028626 · ClinicalTrials.gov registry record · Phase 2
Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00028626: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00028626 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00028626, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Embolization blocks blood flow to part of an organ and/or tumor. Blocking the portal vein on one side of the liver may cause the opposite side of the liver to increase in size and decrease the risk of liver failure following surgery. PURPOSE: Phase II trial to study the effectiveness of portal vein embolization in treating patients who have liver metastases from primary colorectal cancer.
Interventions
- DRUG embolization therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-08 |
| Est. Completion | 2004-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00028626
The ClinicalTrials.gov registry entry for NCT00028626 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which embolization therapy is the first listed.
NCT00028626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00028626 about?
NCT00028626 is a clinical study titled "Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer". RATIONALE: Embolization blocks blood flow to part of an organ and/or tumor. Blocking the portal vein on one side of the liver may cause the opposite side of the liver to increase in size and decrease the risk of liver failure following surgery. PURPOSE: Phase II trial to study the effectiveness of ...
What is the current status of trial NCT00028626?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-08. Estimated completion is 2004-01.
What interventions are being tested in trial NCT00028626?
The interventions under investigation include: embolization therapy (DRUG).
Who is sponsoring clinical trial NCT00028626?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.